</ iframe></noscript> <!-- End Google Tag Manager (noscript) --> <div id="page" class="site"><a aria-label="skip to content" class="skip-link" href="#content">Weiter zum Inhalt</a> <header class="site-header header-layout-three header-layout-seven header-layout-eight" itemscope itemtype="http://schema.org/WPHeader"> <div class="header-holder"> <div class="header-m" style="background-image:url(https://blog.covance.com/wp-content/uploads/2020/04/cropped-dna-blog-header-4.jpg)"> <div class="container"> <div class="site-branding" itemscope itemtype="http://schema.org/Organization"> <h1 class="site-title" itemprop="name"><a href="https://de.covance.com/sdblog/" rel="home" itemprop="url">Einblicke in unsere Labore, von denen Sie in Ihren profitieren können</a></h1> <p class="site-description" itemprop="description">Covance by LabCorp Blog</p> </div> </div> </div> </div> <div class="sticky-holder"></div> <div class="header-b"> <div class="container"> <button aria-label="primary menu toggle" id="primary-toggle-button"><i class="fa fa-bars"></i>Navigation</button> <nav id="site-navigation" class="main-navigation" itemscope itemtype="http://schema.org/SiteNavigationElement"> <div class="menu-main-container"><ul id="primary-menu" class="menu"><li id="menu-item-6077" class="menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-item-6077"><a href="https://de.covance.com/sdblog/" aria-current="page">Startseite</a></li> <li id="menu-item-5821" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5821"><a href="https://blog.covance.com/industry/">Branche</a> <ul class="sub-menu"> <li id="menu-item-5824" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5824"><a href="https://blog.covance.com/industry/device/">Geräte</a></li> <li id="menu-item-5825" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5825"><a href="https://blog.covance.com/industry/drug-development/">Wirkstoffe</a></li> <li id="menu-item-5822" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5822"><a href="https://blog.covance.com/industry/chemical/">Chemikalien</a></li> <li id="menu-item-5823" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5823"><a href="https://blog.covance.com/industry/crop/">Nutzpflanzen</a></li> </ul> </li> <li id="menu-item-5828" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5828"><a href="https://blog.covance.com/phase/">Phase</a> <ul class="sub-menu"> <li id="menu-item-5829" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5829"><a href="https://blog.covance.com/phase/discovery/">Entdeckung</a></li> <li id="menu-item-5835" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5835"><a href="https://blog.covance.com/phase/preclinical-nonclinical/">Präklinisch/nichtklinisch</a></li> <li id="menu-item-5831" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5831"><a href="https://blog.covance.com/phase/phase-i-iia/">Phase I-IIa</a></li> <li id="menu-item-5832" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5832"><a href="https://blog.covance.com/phase/phase-iib-iii/">Phase IIb-III</a></li> <li id="menu-item-5833" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5833"><a href="https://blog.covance.com/phase/pilot/">Pilot</a></li> <li id="menu-item-5834" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5834"><a href="https://blog.covance.com/phase/pivotal/">Pivot</a></li> <li id="menu-item-5830" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5830"><a href="https://blog.covance.com/phase/formulation-packaging/">Rezeptur, Verpackung etc.</a></li> </ul> </li> <li id="menu-item-5836" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5836"><a href="https://blog.covance.com/molecule-type/">Molekültyp</a> <ul class="sub-menu"> <li id="menu-item-5837" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5837"><a href="https://blog.covance.com/molecule-type/biologics/">Biologics</a></li> <li id="menu-item-5841" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5841"><a href="https://blog.covance.com/molecule-type/small-molecules/">Kleine Moleküle</a></li> <li id="menu-item-5839" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5839"><a href="https://blog.covance.com/molecule-type/biosimilars/">Biosimilars</a></li> <li id="menu-item-5838" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5838"><a href="https://blog.covance.com/molecule-type/biomarkers/">Biomarker</a></li> <li id="menu-item-5840" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5840"><a href="https://blog.covance.com/molecule-type/cell-gene-therapies/">Zell-/Gentherapien</a></li> </ul> </li> <li id="menu-item-5844" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5844"><a href="https://blog.covance.com/data-informatics/">Daten/Informatik</a> <ul class="sub-menu"> <li id="menu-item-5842" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5842"><a href="https://blog.covance.com/data-informatics/send/">SEND</a></li> <li id="menu-item-5845" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5845"><a href="https://blog.covance.com/data-informatics/modeling/">Modellierung</a></li> <li id="menu-item-5846" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5846"><a href="https://blog.covance.com/data-informatics/patient-recruitment/">Patientenanwerbung</a></li> <li id="menu-item-5843" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5843"><a href="https://blog.covance.com/data-informatics/xcellerate/">Xcellerate</a></li> </ul> </li> <li id="menu-item-5827" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5827"><a href="https://blog.covance.com/about-covance/">Über uns</a> <ul class="sub-menu"> <li id="menu-item-5704" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5704"><a href="https://blog.covance.com/about-covance/careers-and-culture/">Karriere und Kultur</a></li> <li id="menu-item-5792" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5792"><a href="http://response.covance.com/contact-us?elqCampaignId=399&cid=Web_Clk_CVD_blog_megamenunav_0615_399">Kontakt</a></li> <li id="menu-item-5791" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5791"><a href="https://de.covance.com/">Covance.com</a></li> </ul> </li> </ul></div> </nav><!-- #site-navigation --> <div class="right"> <div class="tools"> <div class="form-section"> <button aria-label="search form toggle" id="btn-search"><i class="fa fa-search"></i></button> <div class="form-holder"> <form role="search" method="get" class="search-form" action="https://de.covance.com/sdblog/"> <label> <span class="screen-reader-text">Suche nach:</span> <input type="search" class="search-field" placeholder="Suche ..." value="" name="s"/> </label> <input type="submit" class="search-submit" value="Suchen"/> </form> </div> </div> </div> <ul class="social-networks"> <li><a href="https://www.linkedin.com/company/covancebylabcorp" target="_blank" rel="nofollow"><i class="fab fa-linkedin"></i></a></li> <li><a href="https://twitter.com/covance" target="_blank" rel="nofollow"><i class="fab fa-twitter-square"></i></a></li> <li><a href="https://www.facebook.com/CovanceByLabcorp" target="_blank" rel="nofollow"><i class="fab fa-facebook"></i></a></li> <li><a href="http://www.youtube.com/user/CovanceMedia" target="_blank" rel="nofollow"><i class="fab fa-youtube"></i></a></li> </ul> </div> </div> </div> </header> <div class="banner banner-layout-two"> <div class="container"> <div class="owl-carousel slider-layout-two"> <div class="item"><div class="grid-holder"> <div class="grid-item image-size"> <img width="817" height="649" src="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg" class="attachment-blossom-feminine-slider-two-big size-blossom-feminine-slider-two-big wp-post-image" alt="Diabetische Nierenkrankheit" srcset="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg 817w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-300x238.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-768x610.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-76x60.jpg 76w" sizes="(max-width: 817px) 100vw, 817px" data-attachment-id="7842" data-permalink="https://blog.covance.com/2021/04/recognizing-national-kidney-month-by-breaking-down-barriers-to-improve-clinical-trials-for-glomerular-diseases/biomarkers-for-diabetic-kidney-disease-3/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg" data-orig-size="817,649" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-300x238.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg"/> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/04/recognizing-national-kidney-month-by-breaking-down-barriers-to-improve-clinical-trials-for-glomerular-diseases/">Anerkennung des National Kidney Month durch Abbau von Barrieren zur Verbesserung klinischer Studien für glomeruläre Erkrankungen</a></h2> </div> </div> <div class="grid-item"> <img width="460" height="310" src="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-460x310.jpg" class="attachment-blossom-feminine-slider-two size-blossom-feminine-slider-two wp-post-image" alt="DCTBlog" srcset="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-460x310.jpg 460w, https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-91x60.jpg 91w" sizes="(max-width: 460px) 100vw, 460px" data-attachment-id="7836" data-permalink="https://blog.covance.com/2021/03/decentralized-clinical-trials/dctblog/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog.jpg" data-orig-size="618,407" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-300x198.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog.jpg"/> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/03/decentralized-clinical-trials/">Dezentralisierte klinische Studien (DCT) Monatlicher Blog – März 2021</a></h2> </div> </div> <div class="grid-item"> <img width="454" height="310" src="https://blog.covance.com/wp-content/uploads/2021/03/KP2-454x310.jpg" class="attachment-blossom-feminine-slider-two size-blossom-feminine-slider-two wp-post-image" alt="KP2" data-attachment-id="7804" data-permalink="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/kp2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg" data-orig-size="454,606" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2-225x300.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg"/> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/">Erweiterung des Supports für klinische Studien in Europa, Nahost und Afrika mit einer neuen automatisierten Kit-Produktionslinie</a></h2> </div> </div> </div></div> </div> </div> </div> <div class="container main-content"> <div id="content" class="site-content"> <div class="row"> <div id="primary" class="content-area"> <main id="main" class="site-main"> <article id="post-7799" class="post-7799 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia tag-clinical-pharmacology tag-clinical-trials wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Leeds-Bild" data-attachment-id="7800" data-permalink="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/leeds-image-updated-03-15-21-1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1.png" data-orig-size="1287,601" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-300x140.png" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-1024x478.png"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/&title=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK&Body=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark">Covance von Labcorp gibt Pläne für einen neuen Standort für klinische Pharmakologie in Leeds, Vereinigtes Königreich, bekannt</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-23T09:25:20-04:00" itemprop="dateModified">Dienstag, 23. März 2021</time><time class="updated" datetime="2021-03-23T09:25:16-04:00" itemprop="datePublished">Dienstag, 23. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Derzeit wird daran gearbeitet, ein bestehendes Gebäude im Herzen des Tempelbezirks von Leeds in eine zweckmäßige Einrichtung umzuwandeln, die die Messlatte für klinisches Verhalten und freiwilliges Engagement höher legt. Der neue Standort wird unsere beiden bestehenden zentralen Standorte in Leeds in einer Einrichtung zusammenfassen, die nur wenige Minuten von Krankenhäusern … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7799 --> <article id="post-7756" class="post-7756 post type-post status-publish format-standard has-post-thumbnail hentry category-discovery category-drug-development category-oncology category-phase-i-iia tag-flow-cytometry wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Greenfield3801" srcset="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg 1024w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-768x512.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg 1500w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7760" data-permalink="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/greenfield3801/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg" data-orig-size="1500,1000" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/&title=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation&Body=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark">Minimale Resterkrankung durch Durchflusszytometrie: Neueste Erkenntnisse zur Validierung</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-22T16:43:59-04:00" itemprop="dateModified">Montag, 22. März 2021</time><time class="updated" datetime="2021-03-22T16:43:56-04:00" itemprop="datePublished">Montag, 22. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Trotz der Entwicklung von zellulären und antikörperbasierten Therapeutika, die bösartige Zellen eliminieren, kann es bei Patienten zu einem Rückfall kommen, die eine komplette Remission oder ein Ansprechen erreicht hatten. Immer mehr Hinweise deuten darauf hin, dass das Vorhandensein einer messbaren/minimalen Resterkrankung (MRD) im Knochenmark (BM)-Gewebe ein, wenn nicht sogar der stärkste prognostische Faktor für den Krankheitsverlauf ist ... </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7756 --> <article id="post-7811" class="post-7811 post type-post status-publish format-standard has-post-thumbnail hentry category-discovery category-drug-development category-phase-i-iia wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="3-22-2021 1-19-21 PM" data-attachment-id="7812" data-permalink="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/3-22-2021-1-19-21-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM.jpg" data-orig-size="828,408" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM-300x148.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/&title=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015 https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015&Body=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="bookmark">5 Gründe, unseren virtuellen Workshop für Neurologie-Biomarker am 15. April nicht zu verpassen</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-23T16:30:09-04:00" itemprop="dateModified">Dienstag, 23. März 2021</time><time class="updated" datetime="2021-03-22T16:35:21-04:00" itemprop="datePublished">Montag, 22. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Am 15. April 2021 werden wir unseren virtuellen Workshop „Weiterentwicklung Ihrer neurodegenerativen Biomarker-Strategie über die Entdeckung hinaus“ veranstalten. Lesen Sie weiter, um mehr über unsere Gründe für die Organisation dieses Events und die dort gebotenen Einblicke zu erfahren. Danach sollten Sie sich unbedingt anmelden, um Ihren Platz zu reservieren.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7811 --> <article id="post-7806" class="post-7806 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-metabolic-endocrine category-preclinical-nonclinical tag-qwba wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/lab1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Lab1" srcset="https://blog.covance.com/wp-content/uploads/2021/03/lab1-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/lab1-300x199.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/lab1-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg 906w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7810" data-permalink="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/lab1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg" data-orig-size="906,601" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1-300x199.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/&title=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered&Body=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="bookmark">Quantitative Ganzkörper-Autoradiographie (QWBA): Antworten auf Ihre Fragen</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-22T14:27:30-04:00" itemprop="dateModified">Montag, 22. März 2021</time><time class="updated" datetime="2021-03-22T14:27:26-04:00" itemprop="datePublished">Montag, 22. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>QWBA hilft bei der Charakterisierung der Verteilung eines Wirkstoffs im Körper und liefert wichtige Stoffwechselinformationen für Ihr präklinisches Wirkstoffentwicklungsprogramm. Hier erhalten wir Ratschläge von zwei erfahrenen Studienleitern zu häufigen Fragen und Herausforderungen bezüglich QWBA.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7806 --> <article id="post-7783" class="post-7783 post type-post status-publish format-standard has-post-thumbnail hentry category-device category-phase-i-iia tag-eu-mdr tag-med-device wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/EU-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="EU" srcset="https://blog.covance.com/wp-content/uploads/2021/03/EU-450x300.png 450w, https://blog.covance.com/wp-content/uploads/2021/03/EU-300x200.png 300w, https://blog.covance.com/wp-content/uploads/2021/03/EU-1024x682.png 1024w, https://blog.covance.com/wp-content/uploads/2021/03/EU-768x512.png 768w, https://blog.covance.com/wp-content/uploads/2021/03/EU-90x60.png 90w, https://blog.covance.com/wp-content/uploads/2021/03/EU.png 1280w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7784" data-permalink="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/eu/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/EU.png" data-orig-size="1280,853" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/EU-300x200.png" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/EU-1024x682.png"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/&title=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines&Body=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="bookmark">Umsetzung und Fristen von EU-MDR und IVDR</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/lilianaomar/">Liliana Omar, Projektleiterin Regulatory and Quality</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-15T15:46:19-04:00" itemprop="dateModified">Montag, 15. März 2021</time><time class="updated" datetime="2021-03-15T15:46:16-04:00" itemprop="datePublished">Montag, 15. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Vorschlag für eine Verzögerung der EU-MDR-Anwendung Die Europäische Verordnung über Medizinprodukte (MDR) und die In-Vitro-Diagnostik-Verordnung (IVDR) sind am 25 Mai 2017 in Kraft getreten und ersetzen die Richtlinien über Medizinprodukte (MDD), aktive implantierbare medizinische Geräte (AIMD) und In-Vitro-Diagnostika (IVDD).</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7783 --> <article id="post-7765" class="post-7765 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia category-phase-iib-iii category-xcellerate tag-big-data tag-internet-of-things tag-patient-care-technology tag-xcellerate wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="3-15-2021" srcset="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg 542w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7792" data-permalink="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/3-15-2021-1-04-34-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg" data-orig-size="542,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/&title=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials&Body=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark">Sechs automatisierte klinische Warnmeldungen, die Sie benötigen, um die Effizienz Ihrer klinischen Studien zu steigern</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/gaylekeenan/">Gayle Keenan, Stellvertretende Direktorin, Xcellerate CS</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-18T15:46:50-04:00" itemprop="dateModified">Donnerstag, 18. März 2021</time><time class="updated" datetime="2021-03-15T14:08:15-04:00" itemprop="datePublished">Montag, 15. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Was ist eine automatisierte klinische Warnmeldungen? Automatisierte klinische Warnmeldungen überwachen kontinuierlich die Studiendaten und senden Warnungen und Benachrichtigungen an die Mitglieder des Projektteams für klinische Studien, basierend auf bestimmten Leistungskriterien für Studien, Länder, Standorte oder Probanden, um die Überwachung klinischer Studien und das Qualitätsmanagement zu verbessern.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7765 --> <article id="post-7772" class="post-7772 post type-post status-publish format-standard has-post-thumbnail hentry category-chemical category-preclinical-nonclinical tag-chemical-testing tag-reach tag-regulatory wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="ncblog1" data-attachment-id="7775" data-permalink="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/ncblog1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1.jpg" data-orig-size="823,621" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1-300x226.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/&title=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe " rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe &Body=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="bookmark">Bewältigung von Herausforderungen in den Prozessen der Charakterisierung, Beurteilung und Registrierung Ihrer UVCB in Europa </a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="bookmark"><time class="entry-date published updated" datetime="2021-04-05T15:19:47-04:00" itemprop="dateModified">Montag, 5. April 2021</time><time class="updated" datetime="2021-03-08T17:51:41-05:00" itemprop="datePublished">Montag, 8. März 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Die Forderung im Rahmen der europäischen Vorschriften nach einer detaillierten Bewertung des Umweltrisikos von UCVB ist sowohl für die Branche als auch die Aufsichtsbehörden eine Herausforderung. Lesen Sie weiter, um mehr über die Herausforderungen zu erfahren und Möglichkeiten kennenzulernen, sie zu meistern.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7772 --> <article id="post-7752" class="post-7752 post type-post status-publish format-standard has-post-thumbnail hentry category-commercialization category-decentralized-clinical-trials category-drug-development category-phase-i-iia category-phase-iib-iii category-pivotal tag-decentralized-clinical-trials-dct wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="DCT2" srcset="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/DCT2-89x60.jpg 89w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7753" data-permalink="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/dct2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg" data-orig-size="537,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-300x202.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/&title=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021 https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021&Body=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark">Dezentralisierte klinische Studien (DCT) Monatlicher Blog – Februar 2021</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/janemyles/">Jane Myles, Direktorin, Implementierung dezentraler klinischer Studien, bei Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-09T17:22:23-05:00" itemprop="dateModified">Dienstag, 9. März 2021</time><time class="updated" datetime="2021-02-25T17:19:00-05:00" itemprop="datePublished">Donnerstag, 25. Februar 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Willkommen zur Februar-2021-Ausgabe des Blogs von Covance by Labcorp Decentralized Clinical Trials. Die meisten unserer Blogs konzentrieren sich auf interessante Informationen, die wir von Sponsoren erhalten, neue Entwicklungen bei Covance by Labcorp oder interessante Herausforderungen, denen wir begegnen, wenn wir mit Sponsoren zusammenarbeiten. Diesen Monat wollen wir jedoch ... </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7752 --> <article id="post-7733" class="post-7733 post type-post status-publish format-standard has-post-thumbnail hentry category-crop category-preclinical-nonclinical category-vaccine-molecule-type tag-endocrine-disruptor wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/02/Tractor-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Traktor" data-attachment-id="7736" data-permalink="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/tractor/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor.jpg" data-orig-size="642,411" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor-300x192.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/&title=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements&Body=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark">Erneuerung von Pestizid-Wirkstoffen: Wie die Anforderungen der EU bezüglich endokriner Disruptoren zu bewältigen sind</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/hyacinth-chin-sue/">Hyacinth Chin Sue, Fachberaterin, CPC Pflanzenschutz</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark"><time class="entry-date published updated" datetime="2021-02-16T14:35:03-05:00" itemprop="dateModified">Dienstag, 16. Februar 2021</time><time class="updated" datetime="2021-02-15T14:46:30-05:00" itemprop="datePublished">Montag, 15. Februar 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Die ED-Bewertung für Wirkstoffe in Pflanzenschutzmitteln trat im November 2018 in der EU in Kraft. Erkenntnisse aus der Bewertung der ersten 65 Wirkstoffe durch die EFSA zeigen, wie Leitlinien und Ausnahmeregelungen angewendet werden. Lesen Sie mehr, um herauszufinden, wie Sie den ED-Bewertungsprozess navigieren und können und wann ... </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7733 --> <article id="post-7713" class="post-7713 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-oncology category-phase-i-iia category-phase-iib-iii wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="MMM" data-attachment-id="7719" data-permalink="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/1-29-2021-2-36-58-pm-2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg" data-orig-size="803,598" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-300x223.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg"/></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Teilen <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/&title=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies&Body=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark">Innovation in der Anreicherung von Plasmazellen für Studien zum multiplen Myelom</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> von <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">Aktualisiert am </span><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark"><time class="entry-date published updated" datetime="2021-01-29T16:48:29-05:00" itemprop="dateModified">Freitag, 29. Januar 2021</time><time class="updated" datetime="2021-02-08T07:00:00-05:00" itemprop="datePublished">Montag, 8. Februar 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Syndecan-1 (SDC1), auch bekannt als CD138, ist ein bekannter und spezifischer Plasmazellmarker, der auf der Oberfläche von Plasmazellen des Multiplen Myeloms stark exprimiert wird. Da es eine Herausforderung sein kann, die geringe Anzahl bösartiger Plasmazellen innerhalb des großen Anteils der aus einem Knochen gewonnenen Zellen zu erkennen ... </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7713 --><div class="pagination"></div> </main><!-- #main --> </div><!-- #primary --> <aside id="secondary" class="widget-area" itemscope itemtype="http://schema.org/WPSideBar"> <section id="nav_menu-7" class="widget widget_nav_menu"><h2 class="widget-title" itemprop="name">Sprachen:</h2><div class="menu-languages-container"><ul id="menu-languages" class="menu"><li id="menu-item-2536" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2536"><a href="https://zh.covance.com/sdblog/">简体中文</a></li> <li id="menu-item-2537" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2537"><a href="https://fr.covance.com/sdblog/">Français</a></li> <li id="menu-item-2538" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2538"><a href="https://de.covance.com/sdblog/">English</a></li> <li id="menu-item-2539" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2539"><a href="https://ja.covance.com/sdblog/">日本語</a></li> <li id="menu-item-2540" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2540"><a href="https://es.covance.com/sdblog/">Español</a></li> <li id="menu-item-2543" class="menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-item-2543"><a href="https://de.covance.com/sdblog/" aria-current="page">Deutsch</a></li> </ul></div></section><section id="categories-2" class="widget widget_categories"><h2 class="widget-title" itemprop="name">Kategorie</h2> <ul> <li class="cat-item cat-item-477"><a href="https://blog.covance.com/about-covance/">Über Covance by Labcorp</a> (1) </li> <li class="cat-item cat-item-94"><a href="https://blog.covance.com/industry/drug-development/analytical-services/">Analytische Dienstleistungen</a href="https://blog.covance.com/category/drug-development/analytical-services/" mptagindex="1"> (3) </li> <li class="cat-item cat-item-586"><a href="https://blog.covance.com/industry/drug-development/antibodies/">Antikörper</a> (1) </li> <li class="cat-item cat-item-491"><a href="https://blog.covance.com/therapeutic-area/autoimmune-inflammatory/">Autoimmun/Entzündungen</a> (11) </li> <li class="cat-item cat-item-512"><a href="https://blog.covance.com/molecule-type/biologics/">Biologics</a> (13) </li> <li class="cat-item cat-item-515"><a href="https://blog.covance.com/molecule-type/biomarkers/">Biomarker</a> (11) </li> <li class="cat-item cat-item-514"><a href="https://blog.covance.com/molecule-type/biosimilars/">Biosimilars</a> (4) </li> <li class="cat-item cat-item-492"><a href="https://blog.covance.com/therapeutic-area/cardiology/">Kardiologie</a> (3) </li> <li class="cat-item cat-item-286"><a href="https://blog.covance.com/about-covance/careers-and-culture/">Karriere und Kultur</a> (58) </li> <li class="cat-item cat-item-516"><a href="https://blog.covance.com/molecule-type/cell-gene-therapies/">Zell-/Gentherapien</a> (5) </li> <li class="cat-item cat-item-458"><a href="https://blog.covance.com/industry/chemical/">Chemikalien</a> (15) </li> <li class="cat-item cat-item-11"><a href="https://blog.covance.com/industry/drug-development/clinical-development/">Klinische Entwicklung</a href="https://blog.covance.com/category/drug-development/clinical-development/" mptagindex="1"> (45) </li> <li class="cat-item cat-item-10"><a href="https://blog.covance.com/industry/drug-development/central-laboratory-services/">Klinische Prüfung</a href="https://blog.covance.com/category/drug-development/central-laboratory-services/" mptagindex="1"> (12) </li> <li class="cat-item cat-item-585"><a href="https://blog.covance.com/phase/commercialization/">Vermarktung</a> (7) </li> <li class="cat-item cat-item-180"><a href="https://blog.covance.com/industry/drug-development/consulting/">Beratung</a href="https://blog.covance.com/category/drug-development/consulting/" mptagindex="1"> (3) </li> <li class="cat-item cat-item-479"><a href="https://blog.covance.com/industry/crop/">Nutzpflanzen</a> (13) </li> <li class="cat-item cat-item-517"><a href="https://blog.covance.com/data-informatics/">Daten/Informatik</a> (15) </li> <li class="cat-item cat-item-632"><a href="https://blog.covance.com/decentralized-clinical-trials/">Dezentralisierte klinische Studien</a> (9) </li> <li class="cat-item cat-item-478"><a href="https://blog.covance.com/industry/device/">Geräte</a> (15) </li> <li class="cat-item cat-item-481"><a href="https://blog.covance.com/phase/discovery/">Entdeckung</a> (6) </li> <li class="cat-item cat-item-64"><a href="https://blog.covance.com/industry/drug-development/">Wirkstoffe</a> (177) </li> <li class="cat-item cat-item-486"><a href="https://blog.covance.com/phase/formulation-packaging/">Rezeptur, Verpackung etc.</a> (1) </li> <li class="cat-item cat-item-495"><a href="https://blog.covance.com/therapeutic-area/general-medicine/">Allgemeinmedizin</a> (2) </li> <li class="cat-item cat-item-181"><a href="https://blog.covance.com/industry/drug-development/health-economics-market-access/">Health Economics & Market Access</a href="https://blog.covance.com/category/drug-development/health-economics-market-access/" mptagindex="1"> (5) </li> <li class="cat-item cat-item-19"><a href="https://de.covance.com/sdblog/healthcare/">Gesundheitswesen</a href="https://blog.covance.com/category/healthcare/" mptagindex="1"> (1) </li> <li class="cat-item cat-item-571"><a href="https://blog.covance.com/industry/drug-development/immunology/">Immunologie</a> (2) </li> <li class="cat-item cat-item-487"><a href="https://blog.covance.com/industry/">Branche</a> (1) </li> <li class="cat-item cat-item-497"><a href="https://blog.covance.com/therapeutic-area/infectious-disease/">Infektionskrankheiten</a> (3) </li> <li class="cat-item cat-item-603"><a href="https://blog.covance.com/routes/inhalation/">Inhalation</a> (1) </li> <li class="cat-item cat-item-99"><a href="https://blog.covance.com/industry/drug-development/lead-optimization-drug-development/">Lead-Optimierung</a href="https://blog.covance.com/category/drug-development/lead-optimization-drug-development/" mptagindex="1"> (7) </li> <li class="cat-item cat-item-61"><a href="https://blog.covance.com/industry/drug-development/manufacturing-support/">Herstellungsunterstützung</a href="https://blog.covance.com/category/drug-development/manufacturing-support/" mptagindex="1"> (1) </li> <li class="cat-item cat-item-432"><a href="https://blog.covance.com/therapeutic-area/metabolic-endocrine/">Metabolisch/Endokrin</a> (11) </li> <li class="cat-item cat-item-569"><a href="https://blog.covance.com/industry/drug-development/metabolism-pk/">Stoffwechsel & PK</a> (3) </li> <li class="cat-item cat-item-499"><a href="https://blog.covance.com/therapeutic-area/nash/">NASH</a> (6) </li> <li class="cat-item cat-item-500"><a href="https://blog.covance.com/therapeutic-area/nephrology/">Nephrologie</a> (1) </li> <li class="cat-item cat-item-501"><a href="https://blog.covance.com/therapeutic-area/oncology/">Onkologie</a> (37) </li> <li class="cat-item cat-item-614"><a href="https://blog.covance.com/industry/drug-development/safety-assessment/pathology/">Pathologie</a> (1) </li> <li class="cat-item cat-item-520"><a href="https://blog.covance.com/data-informatics/patient-recruitment/">Patientenanwerbung</a> (9) </li> <li class="cat-item cat-item-503"><a href="https://blog.covance.com/therapeutic-area/pediatrics/">Pädiatrie</a> (2) </li> <li class="cat-item cat-item-482"><a href="https://blog.covance.com/phase/phase-i-iia/">Phase I-IIa</a> (20) </li> <li class="cat-item cat-item-483"><a href="https://blog.covance.com/phase/phase-iib-iii/">Phase IIb-III</a> (74) </li> <li class="cat-item cat-item-484"><a href="https://blog.covance.com/phase/pilot/">Pilot</a> (2) </li> <li class="cat-item cat-item-485"><a href="https://blog.covance.com/phase/pivotal/">Pivot</a> (7) </li> <li class="cat-item cat-item-460"><a href="https://blog.covance.com/phase/preclinical-nonclinical/">Präklinisch/nichtklinisch</a> (99) </li> <li class="cat-item cat-item-504"><a href="https://blog.covance.com/therapeutic-area/pulmonary-respiratory/">Pulmonal/Respiratorisch</a> (5) </li> <li class="cat-item cat-item-505"><a href="https://blog.covance.com/therapeutic-area/rare-disease/">Seltene Krankheiten</a> (8) </li> <li class="cat-item cat-item-565"><a href="https://blog.covance.com/regulatory/regulatory-agencies/">Behörden</a> (2) </li> <li class="cat-item cat-item-566"><a href="https://blog.covance.com/regulatory/regulatory-milestones/">Behördliche Meilensteine</a> (1) </li> <li class="cat-item cat-item-506"><a href="https://blog.covance.com/therapeutic-area/renal-hepatic/">Renal/Hepatisch</a> (2) </li> <li class="cat-item cat-item-507"><a href="https://blog.covance.com/therapeutic-area/reproductive-health/">Reproduktive Gesundheit</a> (1) </li> <li class="cat-item cat-item-431"><a href="https://blog.covance.com/safety/risk-management/">Risikomanagement</a href="https://blog.covance.com/category/safety/risk-management/" mptagindex="1"> (4) </li> <li class="cat-item cat-item-602"><a href="https://blog.covance.com/routes/">Routen</a> (1) </li> <li class="cat-item cat-item-238"><a href="https://blog.covance.com/safety/">Sicherheit</a href="https://blog.covance.com/category/safety/" mptagindex="1"> (3) </li> <li class="cat-item cat-item-179"><a href="https://blog.covance.com/industry/drug-development/safety-assessment/">Sicherheitsbeurteilung</a href="https://blog.covance.com/category/drug-development/safety-assessment/" mptagindex="1"> (9) </li> <li class="cat-item cat-item-518"><a href="https://blog.covance.com/data-informatics/send/">SEND</a> (7) </li> <li class="cat-item cat-item-513"><a href="https://blog.covance.com/molecule-type/small-molecules/">Kleine Moleküle</a> (7) </li> <li class="cat-item cat-item-430"><a href="https://blog.covance.com/technology-services/">Technologie-Dienstleistungen</a href="https://blog.covance.com/category/technology-services/" mptagindex="1"> (2) </li> <li class="cat-item cat-item-1"><a href="https://blog.covance.com/uncategorized/">Unkategorisiert</a href="https://blog.covance.com/category/uncategorized/" mptagindex="1"> (2) </li> <li class="cat-item cat-item-510"><a href="https://blog.covance.com/therapeutic-area/vaccine/">Impfstoffe</a> (4) </li> <li class="cat-item cat-item-570"><a href="https://blog.covance.com/molecule-type/vaccine-molecule-type/">Impfstoffe</a> (2) </li> <li class="cat-item cat-item-521"><a href="https://blog.covance.com/data-informatics/xcellerate/">Xcellerate</a> (6) </li> </ul> </section><section id="archives-2" class="widget widget_archive"><h2 class="widget-title" itemprop="name">Archive</h2> <label class="screen-reader-text" for="archives-dropdown-2">Archive</label> <select id="archives-dropdown-2" name="archive-dropdown"> <option value="">Monat auswählen</option> <option value='https://blog.covance.com/2021/04/'> April 2021 </option> <option value='https://blog.covance.com/2021/03/'> März 2021 </option> <option value='https://blog.covance.com/2021/02/'> Februar 2021 </option> <option value='https://blog.covance.com/2021/01/'> Januar 2021 </option> <option value='https://blog.covance.com/2020/12/'> Dezember 2020 </option> <option value='https://blog.covance.com/2020/11/'> November 2020 </option> <option value='https://blog.covance.com/2020/10/'> Oktober 2020 </option> <option value='https://blog.covance.com/2020/09/'> September 2020 </option> <option value='https://blog.covance.com/2020/08/'> August 2020 </option> <option value='https://blog.covance.com/2020/07/'> Juli 2020 </option> <option value='https://blog.covance.com/2020/06/'> Juni 2020 </option> <option value='https://blog.covance.com/2020/05/'> Mai 2020 </option> <option value='https://blog.covance.com/2020/04/'> April 2020 </option> <option value='https://blog.covance.com/2020/03/'> März 2020 </option> <option value='https://blog.covance.com/2020/02/'> Februar 2020 </option> <option value='https://blog.covance.com/2020/01/'> Januar 2020 </option> <option value='https://de.covance.com/sdblog/2019/12/'> Dezember 2019 </option> <option value='https://de.covance.com/sdblog/2019/10/'> Oktober 2019 </option> <option value='https://de.covance.com/sdblog/2019/09/'> September 2019 </option> <option value='https://de.covance.com/sdblog/2019/08/'> August 2019 </option> <option value='https://de.covance.com/sdblog/2019/05/'> Mai 2019 </option> <option value='https://de.covance.com/sdblog/2019/04/'> April 2019 </option> <option value='https://de.covance.com/sdblog/2019/03/'> März 2019 </option> <option value='https://de.covance.com/sdblog/2019/02/'> Februar 2019 </option> <option value='https://de.covance.com/sdblog/2019/01/'> Januar 2019 </option> <option value='https://de.covance.com/sdblog/2018/12/'> Dezember 2018 </option> <option value='https://de.covance.com/sdblog/2018/11/'> November 2018 </option> <option value='https://de.covance.com/sdblog/2018/10/'> Oktober 2018 </option> <option value='https://de.covance.com/sdblog/2018/09/'> September 2018 </option> <option value='https://de.covance.com/sdblog/2018/08/'> August 2018 </option> <option value='https://de.covance.com/sdblog/2018/07/'> Juli 2018 </option> <option value='https://de.covance.com/sdblog/2018/06/'> Juni 2018 </option> <option value='https://de.covance.com/sdblog/2018/05/'> Mai 2018 </option> <option value='https://de.covance.com/sdblog/2018/03/'> März 2018 </option> <option value='https://de.covance.com/sdblog/2018/02/'> Februar 2018 </option> <option value='https://de.covance.com/sdblog/2018/01/'> Januar 2018 </option> <option value='https://de.covance.com/sdblog/2017/12/'> Dezember 2017 </option> <option value='https://de.covance.com/sdblog/2017/11/'> November 2017 </option> <option value='https://de.covance.com/sdblog/2017/10/'> Oktober 2017 </option> <option value='https://de.covance.com/sdblog/2017/09/'> September 2017 </option> <option value='https://de.covance.com/sdblog/2017/08/'> August 2017 </option> <option value='https://de.covance.com/sdblog/2017/07/'> Juli 2017 </option> <option value='https://de.covance.com/sdblog/2017/06/'> Juni 2017 </option> <option value='https://de.covance.com/sdblog/2017/05/'> Mai 2017 </option> <option value='https://de.covance.com/sdblog/2017/04/'> April 2017 </option> <option value='https://de.covance.com/sdblog/2017/03/'> März 2017 </option> <option value='https://de.covance.com/sdblog/2017/02/'> Februar 2017 </option> <option value='https://de.covance.com/sdblog/2017/01/'> Januar 2017 </option> <option value='https://de.covance.com/sdblog/2016/12/'> Dezember 2016 </option> <option value='https://de.covance.com/sdblog/2016/11/'> November 2016 </option> <option value='https://de.covance.com/sdblog/2016/09/'> September 2016 </option> <option value='https://de.covance.com/sdblog/2016/08/'> August 2016 </option> <option value='https://de.covance.com/sdblog/2016/07/'> Juli 2016 </option> <option value='https://de.covance.com/sdblog/2016/06/'> Juni 2016 </option> <option value='https://de.covance.com/sdblog/2016/05/'> Mai 2016 </option> <option value='https://de.covance.com/sdblog/2016/04/'> April 2016 </option> <option value='https://de.covance.com/sdblog/2016/03/'> März 2016 </option> <option value='https://de.covance.com/sdblog/2016/02/'> Februar 2016 </option> <option value='https://de.covance.com/sdblog/2016/01/'> Januar 2016 </option> <option value='https://de.covance.com/sdblog/2015/11/'> November 2015 </option> <option value='https://de.covance.com/sdblog/2015/08/'> August 2015 </option> <option value='https://de.covance.com/sdblog/2015/06/'> Juni 2015 </option> <option value='https://de.covance.com/sdblog/2015/03/'> März 2015 </option> </select> <script type="text/javascript"> /* <![CDATA[ */ (function() { var dropdown = document.getElementById( "archives-dropdown-2" ); function onSelectChange() { if ( dropdown.options[ dropdown.selectedIndex ].value !== '' ) { document.location.href = this.options[ this.selectedIndex ].value; } } dropdown.onchange = onSelectChange; })(); /* ]]> */ </script> </section><section id="tag_cloud-2" class="widget widget_tag_cloud"><h2 class="widget-title" itemprop="name">Tags</h2><div class="tagcloud"><a href="https://blog.covance.com/tag/biologics/" class="tag-cloud-link tag-link-88 tag-link-position-1" style="font-size: 9.4736842105263pt;" aria-label="biologics (5 items)">Biologics</a> <a href="https://blog.covance.com/tag/biomarkers/" class="tag-cloud-link tag-link-20 tag-link-position-2" style="font-size: 16.842105263158pt;" aria-label="Biomarkers (14 items)">Biomarker</a> <a href="https://blog.covance.com/tag/biosimilars/" class="tag-cloud-link tag-link-62 tag-link-position-3" style="font-size: 11.684210526316pt;" aria-label="biosimilars (7 items)">Biosimilars</a> <a href="https://blog.covance.com/tag/cancer/" class="tag-cloud-link tag-link-44 tag-link-position-4" style="font-size: 8pt;" aria-label="cancer (4 items)">Krebs</a> <a href="https://blog.covance.com/tag/careers/" class="tag-cloud-link tag-link-282 tag-link-position-5" style="font-size: 19.052631578947pt;" aria-label="Careers (19 items)">Karriere</a> <a href="https://blog.covance.com/tag/cdx/" class="tag-cloud-link tag-link-79 tag-link-position-6" style="font-size: 8pt;" aria-label="CDx (4 items)">CDx</a> <a href="https://blog.covance.com/tag/central-laboratory-services-2/" class="tag-cloud-link tag-link-76 tag-link-position-7" style="font-size: 10.763157894737pt;" aria-label="central laboratory services (6 items)">Zentrallabordienste</a> <a href="https://blog.covance.com/tag/china/" class="tag-cloud-link tag-link-266 tag-link-position-8" style="font-size: 11.684210526316pt;" aria-label="China (7 items)">China</a> <a href="https://blog.covance.com/tag/clinical-development/" class="tag-cloud-link tag-link-267 tag-link-position-9" style="font-size: 10.763157894737pt;" aria-label="Clinical Development (6 items)">Klinische Entwicklung</a> <a href="https://blog.covance.com/tag/clinical-trials/" class="tag-cloud-link tag-link-152 tag-link-position-10" style="font-size: 16.289473684211pt;" aria-label="clinical trials (13 items)">klinische Studien</a> <a href="https://blog.covance.com/tag/cmc/" class="tag-cloud-link tag-link-605 tag-link-position-11" style="font-size: 9.4736842105263pt;" aria-label="CMC (5 items)">CMC</a> <a href="https://blog.covance.com/tag/commercialization/" class="tag-cloud-link tag-link-189 tag-link-position-12" style="font-size: 13.526315789474pt;" aria-label="commercialization (9 items)">Vermarktung</a> <a href="https://blog.covance.com/tag/companion-diagnostics/" class="tag-cloud-link tag-link-39 tag-link-position-13" style="font-size: 10.763157894737pt;" aria-label="Companion Diagnostics (6 items)">Therapiebegleitende Diagnostik</a> <a href="https://blog.covance.com/tag/covance/" class="tag-cloud-link tag-link-14 tag-link-position-14" style="font-size: 18.315789473684pt;" aria-label="Covance (17 items)">Covance</a> <a href="https://blog.covance.com/tag/covid-19/" class="tag-cloud-link tag-link-550 tag-link-position-15" style="font-size: 17.763157894737pt;" aria-label="COVID-19 (16 items)">COVID-19</a> <a href="https://blog.covance.com/tag/cra/" class="tag-cloud-link tag-link-274 tag-link-position-16" style="font-size: 9.4736842105263pt;" aria-label="CRA (5 items)">Klinischer Monitor</a> <a href="https://blog.covance.com/tag/cro/" class="tag-cloud-link tag-link-156 tag-link-position-17" style="font-size: 10.763157894737pt;" aria-label="CRO (6 items)">CRO</a> <a href="https://blog.covance.com/tag/crop-protection/" class="tag-cloud-link tag-link-453 tag-link-position-18" style="font-size: 11.684210526316pt;" aria-label="Crop Protection (7 items)">Pflanzenschutz</a> <a href="https://blog.covance.com/tag/dart/" class="tag-cloud-link tag-link-82 tag-link-position-19" style="font-size: 8pt;" aria-label="dart (4 items)">DART</a> <a href="https://blog.covance.com/tag/data-management/" class="tag-cloud-link tag-link-271 tag-link-position-20" style="font-size: 8pt;" aria-label="data management (4 items)">Datenmanagement</a> <a href="https://blog.covance.com/tag/decentralized-clinical-trials-dct/" class="tag-cloud-link tag-link-591 tag-link-position-21" style="font-size: 13.526315789474pt;" aria-label="Decentralized Clinical Trials (DCT) (9 items)">Dezentralisierte klinische Studien (DCT)</a> <a href="https://blog.covance.com/tag/decentralized-trials/" class="tag-cloud-link tag-link-588 tag-link-position-22" style="font-size: 9.4736842105263pt;" aria-label="Decentralized Trials (5 items)">Dezentralisierte Studien</a> <a href="https://blog.covance.com/tag/diabetes/" class="tag-cloud-link tag-link-335 tag-link-position-23" style="font-size: 11.684210526316pt;" aria-label="Diabetes (7 items)">Diabetes</a> <a href="https://blog.covance.com/tag/diabetic-kidney-disease/" class="tag-cloud-link tag-link-369 tag-link-position-24" style="font-size: 10.763157894737pt;" aria-label="Diabetic Kidney Disease (6 items)">Diabetische Nierenkrankheit</a> <a href="https://blog.covance.com/tag/drug-development/" class="tag-cloud-link tag-link-268 tag-link-position-25" style="font-size: 22pt;" aria-label="Drug Development (28 items)">Wirkstoffentwicklung</a> <a href="https://blog.covance.com/tag/drug-safety/" class="tag-cloud-link tag-link-291 tag-link-position-26" style="font-size: 11.684210526316pt;" aria-label="Drug Safety (7 items)">Wirkstoffsicherheit</a> <a href="https://blog.covance.com/tag/fda/" class="tag-cloud-link tag-link-97 tag-link-position-27" style="font-size: 16.842105263158pt;" aria-label="FDA (14 items)">FDA</a> <a href="https://blog.covance.com/tag/informatics/" class="tag-cloud-link tag-link-270 tag-link-position-28" style="font-size: 9.4736842105263pt;" aria-label="informatics (5 items)">Informatik</a> <a href="https://blog.covance.com/tag/market-access/" class="tag-cloud-link tag-link-203 tag-link-position-29" style="font-size: 12.605263157895pt;" aria-label="Market Access (8 items)">Marktzugang</a> <a href="https://blog.covance.com/tag/med-device/" class="tag-cloud-link tag-link-555 tag-link-position-30" style="font-size: 9.4736842105263pt;" aria-label="Med Device (5 items)">Medizinische Geräte</a> <a href="https://blog.covance.com/tag/medical-device/" class="tag-cloud-link tag-link-445 tag-link-position-31" style="font-size: 9.4736842105263pt;" aria-label="medical device (5 items)">Medizinisches Gerät</a> <a href="https://blog.covance.com/tag/nafld/" class="tag-cloud-link tag-link-269 tag-link-position-32" style="font-size: 8pt;" aria-label="NAFLD (4 items)">NAFLD</a> <a href="https://blog.covance.com/tag/nash/" class="tag-cloud-link tag-link-251 tag-link-position-33" style="font-size: 10.763157894737pt;" aria-label="NASH (6 items)">NASH</a> <a href="https://blog.covance.com/tag/patient-centricity/" class="tag-cloud-link tag-link-353 tag-link-position-34" style="font-size: 14.263157894737pt;" aria-label="Patient Centricity (10 items)">Patientenorientierung</a> <a href="https://blog.covance.com/tag/patient-recruitment/" class="tag-cloud-link tag-link-355 tag-link-position-35" style="font-size: 13.526315789474pt;" aria-label="Patient Recruitment (9 items)">Patientenanwerbung</a> <a href="https://blog.covance.com/tag/pharmacovigilance/" class="tag-cloud-link tag-link-438 tag-link-position-36" style="font-size: 11.684210526316pt;" aria-label="Pharmacovigilance (7 items)">Pharmakovigilanz</a> <a href="https://blog.covance.com/tag/precision-medicine/" class="tag-cloud-link tag-link-328 tag-link-position-37" style="font-size: 10.763157894737pt;" aria-label="precision medicine (6 items)">Präzisionsmedizin</a> <a href="https://blog.covance.com/tag/rare-diseases/" class="tag-cloud-link tag-link-264 tag-link-position-38" style="font-size: 10.763157894737pt;" aria-label="Rare Diseases (6 items)">Seltene Krankheiten</a> <a href="https://blog.covance.com/tag/reach/" class="tag-cloud-link tag-link-301 tag-link-position-39" style="font-size: 11.684210526316pt;" aria-label="REACH (7 items)">REACH</a> <a href="https://blog.covance.com/tag/real-world-evidence/" class="tag-cloud-link tag-link-449 tag-link-position-40" style="font-size: 10.763157894737pt;" aria-label="Real-World Evidence (6 items)">Daten zu tatsächlichen Krankheitsverläufen</a> <a href="https://blog.covance.com/tag/regulatory/" class="tag-cloud-link tag-link-324 tag-link-position-41" style="font-size: 17.210526315789pt;" aria-label="Regulatory (15 items)">Behördliche Fragen</a> <a href="https://blog.covance.com/tag/rheumatoid-arthritis/" class="tag-cloud-link tag-link-358 tag-link-position-42" style="font-size: 9.4736842105263pt;" aria-label="Rheumatoid Arthritis (5 items)">Rheumatoide Arthritis</a> <a href="https://blog.covance.com/tag/send/" class="tag-cloud-link tag-link-272 tag-link-position-43" style="font-size: 11.684210526316pt;" aria-label="send (7 items)">Senden</a> <a href="https://blog.covance.com/tag/vaccines/" class="tag-cloud-link tag-link-253 tag-link-position-44" style="font-size: 12.605263157895pt;" aria-label="vaccines (8 items)">Impfstoffe</a> <a href="https://blog.covance.com/tag/xcellerate/" class="tag-cloud-link tag-link-8 tag-link-position-45" style="font-size: 16.289473684211pt;" aria-label="Xcellerate (13 items)">Xcellerate</a></div> </section></aside><!-- #secondary --> </div><!-- .row/not-found --> </div><!-- #content --> </div><!-- .container/.main-content --> <footer id="colophon" class="site-footer" itemscope itemtype="http://schema.org/WPFooter"> <div class="site-info"> <div class="container"> <span class="copyright">© Copyright 2020 Covance Inc. Alle Rechte vorbehalten.</span> </div> </div> </footer><!-- #colophon --> <button aria-label="go to top" id="blossom-top"> <span><i class="fa fa-angle-up"></i>ZUM ANFANG</span> </button> </div><!-- #page --> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/all.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/v4-shims.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/sticky-kit.min.js?ver=1.1.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.min.js?ver=2.2.1'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.aria.min.js?ver=2.0.0'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/jquery.matchHeight.min.js?ver=0.7.2'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/wow.min.js?ver=1.1.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_data = {"lightbox":"","auto":"","loop":"","speed":"3000","animation":"fadeOut","child":"default","sticky":"","sticky_widget":"","header":"eight","url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","rtl":""}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/custom.min.js?ver=2.3.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_ajax = {"url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","startPage":"1","maxPages":"30","nextLink":"https:\/\/blog.covance.com\/page\/2\/","autoLoad":"load_more","loadmore":"Load More Posts","loading":"Loading...","nomore":"No More Post","layouts":"two-col-right","plugin_url":"https:\/\/blog.covance.com\/wp-content\/plugins"}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/ajax.min.js?ver=2.3.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-includes/js/wp-embed.min.js?ver=5.4'></script> <script type='text/javascript' src='https://stats.wp.com/e-202116.js' async='async' defer='defer'></script> <script type='text/javascript'> _stq = window._stq || []; _stq.push([ 'view', {v:'ext',j:'1:9.1',blog:'176650705',post:'0',tz:'-4',srv:'blog.covance.com'} ]); _stq.push([ 'clickTrackerInit', '176650705', '0' ]); </script> <script type="text/javascript"> if(typeof _satellite !== "undefined"){ _satellite.pageBottom(); } </script> </body> <script type="text/javascript">(function(){var MPJsHost=document.createElement('script');MPJsHost.type='text/javascript';MPJsHost.src=('https:'==document.location.protocol?'https://':'http://')+'analytics.convertlanguage.com/urchin.js.php';var s=document.getElementsByTagName('script')[0];s.parentNode.insertBefore(MPJsHost,s);})();</script> <!--Processed by MotionPoint's TransMotion (r) translation engine v17.8.4.0 03/16/2021. Copyright© 2003-2021 MotionPoint Corporation. All Rights Reserved. This product is protected under one or more of the following US patents: 7584216, 7580960, 7627479, 7627817, 7996417, 8065294. Other patents pending.--></html>